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ABSTRACT:  
Introduction:  
A series of salophen-type Cu(II) and Zn(II) dinuclear metal complexes of a Schiff base 
derived from o-phenylenediamine were successfully synthesized, characterized and 
screened for their anticancer activity. 
Methods and Results:  
All compounds were characterized physicochemical and spectral techniques namely 
elemental analysis (C, H, N), magnetic susceptibility (MSB), molar conductivity, thermal 
gravimetric analysis (TGA), infrared (IR) and nuclear magnetic resonance (NMR) 
spectroscopy. The shifting of C=N, C-O phenolic and C-O methoxy peaks and the 
appearance of new peaks assignable to M-N and M-O in IR spectra of the complexes 
indicated the coordination of azomethine N, phenolic O and methoxy O donor atoms with 
metal centers. The disappearance of the hydroxyl peak in 
1
H NMR spectra of the Zn(II) 
complex supported the involvement of phenolic O upon formation of the metal complex. 
The Cu(II) complex was paramagnetic with magnetic moment values of 1.97, close to the 
theoretical spin only magnetic moment, μso, for Cu(II). The compounds were screened for 
anticancer activity against human colon cancer cells (HCT116). The Cu(II) complex 
revealed the highest activity with IC50 value of 21.17  0.76 μM. 
Conclusion:  
The ligand coordinated as a hexadentate ligand through O and N donor atoms of 
phenolic, methoxy and azomethine groups. From anticancer screening, it was observed 
that Cu2(OVanOPD) complex exhibited the highest activity followed by OVanOPD 
ligand and Zn2(OVanOPD) complex. 
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1. Introduction 
 
Transition metal ions with Schiff base ligands have been 
reported to play an important role in biological 
applications. These ligands attracted the attention of 
chemists and biologists due to their wide range of 
applications such as anticancer [1] antibacterial [2], 
antimalarial, antioxidant [3] and antifungal [4] agents. 
Among those ligands are Salophen-type Schiff bases, 
which are versatile ligands due to their facile 
preparation, ability to chelate metal ions through 
coordination with donor atoms. 
2 S. Solihah Khaidir et al. / International Pharmacy Acta, 2020;3(1):e5 
 This open-access article is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License (CC BY-NC 4.0). 
In recent years, the number of people suffering from 
cancer has sharply increased and this disease is 
considered the leading cause of death worldwide [5], 
leaving humanity without any choice but to search for 
new treatment options and strategies.  
The employment of small molecules as anticancer agents 
has great potential, a development pioneered by the 
discovery of a metal-based compound, cisplatin 
([Pt(NH3)2Cl2]), reported by Barnett Rosenberg in 1969. 
Unfortunately, the use of cisplatin was restricted due to 
serious side effects such as neurotoxicity and 
nephrotoxicity, as well as the lack of cell selectivity [6]. 
These drawbacks have prompted searches for alternative 
metal-based drugs in the fight against various types of 
cancer with fewer side effects and better cytotoxic 
properties [7]. 
The salophen-type Schiff base ligands derived from 2-
hydroxy-3-methoxybenzaldehyde may act as the 
bidentate [8], tetradentate [9] and hexadentate [10] 
ligands, to construct mono-, bi- and polynuclear 
complexes likely due to the presence of azomethine N, 
phenolic O, and methoxy O donor atoms.  
In this paper, we reported the synthesis and 
characterization of a salophen Schiff base ligand and its 
copper(II) and zinc(II) complexes containing hexadentate 
Schiff base ligand with O and N donor atoms. The Schiff 
base ligand and its complexes were characterized by 
elemental analysis, magnetic susceptibility, molar 
conductance, thermal gravimetric analysis, IR, and 
1
H 
NMR spectroscopy. The anticancer activity of the Schiff 
base and its metal complexes was studied via an MTT 
assay method against human colon cancer cell lines, 
HCT116. 
 
2. Materials & Methods 
 
2.1 Materials 
 
The chemicals used in this investigation were of 
analytical grade. Ortho-vanillin (OVan), ortho-
phenylenediamine (OPD), copper(II) acetate 
monohydrate and zinc(II) acetate dihydrate were 
purchased from Sigma Aldrich (St Louis, US). All 
chemicals and solvents were used as purchased without 
further purification. 
Elemental analyses of carbon, hydrogen and nitrogen 
were performed on a Thermo Finnigan Flash EA 110 
Elemental Analyzer. Molar conductance of the 
complexes was recorded in acetonitrile (1 x 10
-3
 M) at 
room temperature using Mettler Toledo 730 Series 
conductivity meter, while magnetic measurements were 
performed on solid complexes using Sherwood Auto 
balance. Melting points were measured on a Stuart 
Melting Point SMP10 apparatus and thermal data were 
collected on a TA Instruments Q50 TGA under nitrogen 
atmosphere at the heating rate of 10 C min
-1
 from room 
temperature to 723 K. The IR spectra were recorded as 
KBr discs in the range of 4000-400 cm
-1
 using Perkin-
Elmer FTIR 1600 spectrometer, reported in cm
-1
. 
1
H 
NMR spectra were recorded on Bruker Avance 500 MHz 
NMR spectrometer. Chemical shifts () were reported in 
ppm. 
 
2.2 Synthesis of OVanOPD Ligand  
 
OVan (4.5645 g; 30 mmol) and OPD (1.6221 g; 15 
mmol) were dissolved in 20 mL of absolute ethanol and 
the mixture was subjected to reflux for half an hour 
(Figure 1). The orange precipitate formed was filtered 
off, washed with cold ethanol and air-dried before being 
kept in a vial and stored at room temperature. 
 
2.3 Synthesis of Metal Complexes 
 
Dinuclear Cu2(OVanOPD) complex was obtained by an 
insertion reaction between ligand OVanOPD (0.4514g; 
1.2 mmol) with copper(II) acetate monohydrate 
(0.4792g; 2.4 mmol) (Figure 1). The ligand and metal 
salt were dissolved and refluxed for three hours in 25 mL 
of a 4:1 ratio of absolute ethanol: chloroform. The 
mixture was left to cool to room temperature and the 
brown precipitate obtained was filtered off, washed 
several times with cold ethanol, air-dried and stored in a 
desiccator over blue silica gel. The syntheses of the 
Zn(II) complex were carried out using the same protocol. 
 
 
 
Figure 1. Synthesis of OVanOPD and its metal complexes 
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Table 1. The analytical and physical data of OVanOPD and complexes 
Compounds 
Molecular Formula 
(RMM) 
Colour Yield  (%) 
Melting 
Point (°C) 
Elemental Percentages Found 
(Calculated) 
C (%) H (%) N (%) 
OVanOPD C25H26N2O4  (418.49) Orange 91.53 168-170 69.90 (70.20) 5.36 (5.33) 7.20 (7.44) 
Cu2(OVanOPD) C22H18Cu2N2O4   (501.49) Brown 89.9 >300 53.69 (52.69) 4.47 (3.62) 5.63 (5.59) 
Zn2(OVanOPD) C22H18N2O4Zn2(H2O)   (523.17) Brown 97.79 >300 50.51 (50.41) 4.48 (3.85)  5.13 (5.35) 
 
Table 2. Magnetic susceptibility and molar conductivity value of complexes. 
Compound Molar conductivity, ʌm, (
-1
cm
2
mol
-1
) Effective Magnetic moment, μeff, (B.M.) Suggested Geometry 
Cu2(OVanOPD) 0.23  1.97 Tetrahedral/Square planar 
Zn2(OVanOPD) 0.26 0.00 - 
 
 
2.4 Cytotoxicity Assay 
2.4.1 Cell culture 
 
Roswell Park Memorial Institute, RPMI 1640 Medium 
w/ 25mM HEPES & L-Glutamine, Biowest supplemented 
with 10% heat-inactivated fetal bovine serum (FBS) 
(PAA Laboratories), and 1% penicillin/streptomycin, 
Sigma Aldrich, (St. Louis, US) were used to grow the 
human colorectal carcinoma cell line, HCT116 (ATCC
®
 
CCL-247™).  Cultures were maintained in a humidified 
incubator at 37 C in an atmosphere of 5% CO2. 
 
2.4.2 MTT assay 
 
The methylthiazolyldiphenyl-tetrazolium bromide 
(MTT) assay was measured according to the procedure 
described by [11] with some modification. HCT116 cells 
were plated at 7,000 cells per well and allowed to 
incubate at 37 C for 24 hours. Schiff base OvanOPD 
and its metal complexes were subjected to serial 
dilutions before being added to each well.  The cells 
were treated with the compounds at concentrations 
ranging between 0.01-100 M and incubated at 37 C 
for 72 hours.  
The cytotoxicity of the compounds was assessed using 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide, Sigma Aldrich. Briefly, 50 L of 0.06 mol/L 
MTT solution (Sigma) was added to each well and plates 
were incubated at 37 C for 4 hours. All solutions were 
aspirated and the formazan crystals were dissolved in 
DMSO (Merck). Cell viability was evident by the 
transformation of tetrazolium salt MTT to formazan 
(colored) by mitochondrial dehydrogenases and the plate 
was read at 450 nm. Data generated were used to plot a 
dose-response curve from which the concentration of 
compounds required to kill 50% of the cell population 
(IC50) was determined. 
 
3. Results 
The analytical data of OVanOPD and complexes 
are tabulated in Table 1. The experimental and 
calculated C, H, and N percentage compositions 
were in close accord, indicating that the expected 
compounds have been obtained. Analytical data 
suggested a ratio of 2:1 for metal:ligand for the 
dinuclear OVanOPD complexes. The melting 
points of the ligands were much lower than those of 
the metal complexes, as expected, mostly due to the 
larger molecular size of the complexes and the 
presence of stronger dative covalent bonds in the 
latter. 
 
3.1. Magnetic Susceptibility and Molar Conductivity 
 
The Cu2(OVanOPD) complex revealed a magnetic 
moment of 1.97 B.M. (Table 2), close to the theoretical 
spin only magnetic moment, μso, a value of 1 unpaired 
electron of 1.73 B.M. This is in agreement with Cu(II) d
9
 
configuration. Zn2(OVanOPD) complex has 0 magnetic 
moment values, μso, indicating the absence of unpaired 
electrons, corresponding to Zn(II) d
10 
configuration. The 
experimental molar conductivity data of ligand and 
metal complexes were low, revealing their non-
electrolytic nature (Table 2), much lower than the 
conductivity value of 40 
-1
cm
2
mol
-1
 expected for a 
mono-electrolytic species [12]. 
 
3.2. Infrared Spectroscopy 
 
The important IR bands in ligand and complexes are 
listed in Table 3. The spectra of the ligand showed a 
strong peak at 1612 cm
-1
 corresponding to (C=N), as 
similarly reported by [13, 14]. Upon complexation, this 
band was shifted either to lower or higher wave numbers 
attributed to the bonding of azomethine N to the metal 
center, in accord with the reports by [15,16]. It is 
expected that coordination of nitrogen to the metal center 
through a dative covalent bonding would reduce the 
electron density in the azomethine bond, weakening it, 
thus lowering the (C=N) frequency. In the case of 
(C=N), shifting to higher frequencies, could be 
tentatively explained by the possible occurrence of  
back-bonding from the metal to the nitrogen, 
strengthening the azomethine bond and increasing the 
frequency [17]. 
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Table 3. The IR analytical data for ligand and complexes. 
 
 
The shifting of about 8-10 cm
-1
 of C-O phenolic and C-O 
methoxy stretching vibrations to a lower frequency in the 
spectra of metal complexes was indicative of 
coordination of metal center through phenolic and 
methoxy O atoms. The involvement of azomethine N, 
phenolic O and methoxy O in complexation were 
supported by the presence of new weak peaks in the 
region 507-535 cm
-1
 and 458-482 cm
−1
, in the spectra of 
complexes attributed to (M-N) and (M-O) vibrations, 
respectively, as reported by Lu (2006) [18]. These peaks 
were absent in the spectrum of the free ligand. 
 
3.3. 1H NMR Spectroscopy 
 
The 
1
H NMR data for OVanOPD and Zn2(OVanOPD) 
were tabulated in Table 4. The spectra of the OVanOPD 
show a singlet peak at the chemical shift of 11.20 ppm 
corresponding to the hydroxyl proton. This signal was 
absent in Zn2(OVanOPD) spectra indicating the 
deprotonation of phenolic proton and involvement of 
phenolic O in coordination with the metal center, as it 
was reported by [18-20].  
The azomethine proton of the ligand appeared at 9.93 
ppm and this peak was observed to be shifted to lower 
chemical shifts in the Zn(II) complex inferring shielding 
by the metal centre bonded through azomethine nitrogen 
atom via donation of lone pair of electrons to the metal 
center, an observation similarly reported by [21, 22]. The 
multiplets at the range 6.47-7.90 ppm in ligand and 
complex spectrum were assigned to aromatic protons. 
Two types of aromatic protons were detected i.e. the 
ones that are ortho (one carbon apart) to each other, 
having a coupling constant value of 6-10 Hz, and the 
ones that are meta to each other (two carbon apart), 
having a coupling constant value of 1-3 Hz. As expected, 
there were no para (three carbons apart) protons detected 
in the molecules as no coupling constant with the value 
of 0-1 Hz were recorded.  
The spectra of ligand and complex showed a singlet with 
an integration equivalent to three hydrogens at 3.93 and 
3.77 ppm, respectively, corresponding to the methoxy 
protons. 
 
Table 4. The 1H NMR data of OVanOPD and Zn2(OVanOPD). 
Note: Ar.=Aromatic, s=singlet, d=doublet, dd=doublet of doublet, t=triplet 
 
Table 5. The decomposition temperature and the percentage weight loss of complexes. 
Compounds Molecular formula 
Decomposition 
temperature 
(C) 
Weight loss (%) 
Lost species 
Found Calculated 
Zn2 
(OVanOPD) 
C22H18N2O4Zn2(H2O) 36-80 3.4 3.44 One lattice water molecule 
 
Compound 
Frequency (cm
-1
)
(C=N) (C-O) Phenolic (C-O) Methoxy (M-N) (M-O) 
OVanOPD 1612 1248 1205 - - 
Cu2(OVanOPD) 1610 1242 1194 535 482 
Zn2(OVanOPD) 1613 1237 1192 507 462 
Assignments 
Chemical shift, (ppm) 
C
1
-OH N=C
8
-H 
C
3
-H 
(Ar.) 
C
4
-H  
(Ar.) 
C
5
-H  
(Ar.) 
C
10
-H (Ar.) 
C
11
-H  
(Ar.) 
C
2
-OCH3 
OVanOPD 11.20(s) 9.93(s) 7.29(s) 7.20(dd) 7.13(dd) 6.98(t) - 3.93(s) 
Coupling 
constant,J, (Hz) 
- - - 7.8, 1.4 8.0, 1.4 7.9 -  - 
Number of proton 1 1 1 1 1 1 1 3 
Zn2 (OVanOPD) - 9.01(s) 7.90(dd) 7.39(dd) 7.05(d) 6.88(d) 6.47(t) 3.77(s) 
Coupling 
constant,J, (Hz) 
- - 5.9, 3.5 6.0, 3.3 8.1 7.5 7.7 - 
Number of proton  1 1 1 1 1 1 3 
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3.4. Thermogravimetric Analysis 
 
The thermogravimetric analysis (TGA) was carried out 
for the Zn2(OVanOPD) metal complex to determine the 
presence and the nature bonding of water molecules in 
the complex. Generally, two types of water molecules 
are associated with the complex, either as lattice water or 
coordinated water molecules. The lattice water was lost 
at lower temperatures below 150 °C whereas the 
coordinated water molecule was lost at higher 
temperatures above 150 °C as reported by [23]. The 
decomposition temperature and the percentage weight 
loss of complex are listed in Table 5. The thermogram of 
Zn2(OVanOPD) is displayed in Figure 2. 
 
 
 
Figure 2. Thermogram of Zn2(OVanOPD) 
 
4. Discussion and Conclusion 
 
The ligand and its corresponding metal complexes were 
screened for their cytotoxic activity against human colon 
cancer (HCT116) by MTT assay method using DMSO as 
a negative control. The IC50 of OVanOPD and its 
complexes, from which their respective IC50 and the 
results were tabulated in Table 6. It was observed that 
Cu2(OVanOPD) complex exhibited the highest activity 
followed by OVanOPD ligand and Zn2(OVanOPD) 
complex. All compounds except Zn2(OVanOPD) 
showed better activity than the standard drug, 
carboplatin (IC50 > 100µM). Zn(II) complex exhibited 
the lowest anticancer activity, likely due to the low 
solubility of the complex in DMSO. 
In summary, the Schiff base ligand and its copper(II), 
cobalt(II) and zinc(II) complexes were successfully 
synthesized and characterized using microanalysis, 
TGA, IR ,and 
1
H NMR spectroscopy. The elemental 
analysis data of the complexes revealed that the 
compounds have a molar ratio of 2:1 metal to ligand 
stoichiometry. The ligand coordinated as a hexadentate 
ligand through O and N donor atoms of phenolic, 
methoxy and azomethine groups. The copper complex is 
paramagnetic with a magnetic moment value 1.97. On 
the other hand, the zinc complex is diamagnetic. From 
anticancer screening, it was observed that 
Cu2(OVanOPD) complex exhibited the highest activity 
followed by OVanOPD ligand and Zn2(OVanOPD) 
complex. 
 
Table 6. IC50 values of ligand and complexes. 
Compounds OVanOPD Cu2(OVanOPD) Zn2(OVanOPD) 
IC50, μM 29.40  5.90 21.17  0.76 > 100 
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